0001719844-22-000004.txt : 20220302 0001719844-22-000004.hdr.sgml : 20220302 20220302164348 ACCESSION NUMBER: 0001719844-22-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220302 DATE AS OF CHANGE: 20220302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moore Patrick R. CENTRAL INDEX KEY: 0001719844 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38257 FILM NUMBER: 22704392 MAIL ADDRESS: STREET 1: C/O NATIONAL VISION HOLDINGS, INC. STREET 2: 2435 COMMERCE AVENUE, BLDG. 2200 CITY: DULUTH STATE: GA ZIP: 30096 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: National Vision Holdings, Inc. CENTRAL INDEX KEY: 0001710155 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 464841717 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2435 COMMERCE AVENUE STREET 2: BLDG. 2200 CITY: DULUTH STATE: GA ZIP: 30096-4980 BUSINESS PHONE: (770) 822-3600 MAIL ADDRESS: STREET 1: 2435 COMMERCE AVENUE STREET 2: BLDG. 2200 CITY: DULUTH STATE: GA ZIP: 30096-4980 4 1 wf-form4_164625740391297.xml FORM 4 X0306 4 2022-02-28 0 0001710155 National Vision Holdings, Inc. EYE 0001719844 Moore Patrick R. C/O NATIONAL VISION HOLDINGS, INC., 2435 COMMERCE AVENUE, BLDG. 2200 DULUTH GA 30096-4980 0 1 0 0 SVP, Chief Financial Officer Common Stock 2022-02-28 4 M 0 2393 0 A 18318 D Common Stock 2022-02-28 4 F 0 1080 D 17238 D Restricted Stock Units 2022-02-28 4 M 0 2393 0 D Common Stock 2393.0 11716 D Each restricted stock unit represents a contingent right to receive one share of NVHI common stock. On February 28, 2022, 2,393 restricted stock units vested and 1,080 shares of the Company's common stock were withheld to satisfy tax withholding obligations. The closing price on February 28, 2022 of the Company's common stock on NASDAQ was $36.67 per share. On February 28, 2020, the reporting person was granted 7,180 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. /s/ Jared Brandman, as Attorney-in-Fact 2022-03-02